Singh et al., 2021 - Google Patents
The genomic landscape of thyroid cancer tumourigenesis and implications for immunotherapySingh et al., 2021
View HTML- Document ID
- 13123870574109768453
- Author
- Singh A
- Ham J
- Po J
- Niles N
- Roberts T
- Lee C
- Publication year
- Publication venue
- Cells
External Links
Snippet
Thyroid cancer is the most prevalent endocrine malignancy that comprises mostly indolent differentiated cancers (DTCs) and less frequently aggressive poorly differentiated (PDTC) or anaplastic cancers (ATCs) with high mortality. Utilisation of next-generation sequencing …
- 201000002510 thyroid cancer 0 title abstract description 77
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Singh et al. | The genomic landscape of thyroid cancer tumourigenesis and implications for immunotherapy | |
| Malki et al. | Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements | |
| Rodriquenz et al. | MSI and EBV positive gastric cancer’s subgroups and their link with novel immunotherapy | |
| Vrána et al. | From tumor immunology to immunotherapy in gastric and esophageal cancer | |
| Romei et al. | A narrative review of genetic alterations in primary thyroid epithelial cancer | |
| Alessandrini et al. | Proposed molecular and miRNA classification of gastric cancer | |
| Kudelova et al. | Genetic heterogeneity, tumor microenvironment and immunotherapy in triple-negative breast cancer | |
| Inamura | Diagnostic and therapeutic potential of microRNAs in lung cancer | |
| Zhang et al. | Targeting loss of heterozygosity: a novel paradigm for cancer therapy | |
| Ghidini et al. | Immune-based therapies and the role of microsatellite instability in pancreatic cancer | |
| Giunta et al. | Epigenetic regulation in melanoma: facts and hopes | |
| Mulet-Margalef et al. | Challenges and therapeutic opportunities in the dMMR/MSI-H colorectal cancer landscape | |
| Angulo et al. | The role of epigenetics in the progression of clear cell renal cell carcinoma and the basis for future epigenetic treatments | |
| Ravi et al. | Identification of targetable lesions in anaplastic thyroid cancer by genome profiling | |
| Auguste et al. | Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) beyond SMARCA4 mutations: a comprehensive genomic analysis | |
| Dion et al. | The landscape and therapeutic implications of molecular profiles in epithelial ovarian cancer | |
| Larrew et al. | Molecular classification and therapeutic targets in ependymoma | |
| Ray et al. | Subgroup-specific diagnostic, prognostic, and predictive markers influencing pediatric medulloblastoma treatment | |
| Awada et al. | A comprehensive review of the genomics of multiple myeloma: Evolutionary trajectories, gene expression profiling, and emerging therapeutics | |
| Prete et al. | Poorly differentiated and anaplastic thyroid cancer: Insights into genomics, microenvironment and new drugs | |
| Baumgart et al. | Dysregulated transcriptional control in prostate cancer | |
| Casadei et al. | Targetable pathways in the treatment of retroperitoneal liposarcoma | |
| Florent et al. | BRAF V600-mutated metastatic melanoma and targeted therapy resistance: an update of the current knowledge | |
| Pinto et al. | Molecular biology of pediatric and adult male germ cell tumors | |
| Lu et al. | Genomic variations in pancreatic cancer and potential opportunities for development of new approaches for diagnosis and treatment |